Effectiveness of confidential reports to physicians on their prescribing of antipsychotic medications in nursing homes

Effectiveness of confidential reports to physicians on their prescribing of antipsychotic medications in nursing homes

Abstract Background Antipsychotic medication use in nursing homes is associated with potential for harms. In Ontario, Canada, an agency of the provincial government offers nursing home physicians quarterly audit and feedback on their antipsychotic prescribing. We compared the characteristics of phys...

Full description

Bibliographic Details
Main Authors:	Noah M. Ivers, Monica Taljaard, Vasily Giannakeas, Catherine Reis, Cara L. Mulhall, Jonathan M.C. Lam, Ann N. Burchell, Gerald Lebovic, Susan E. Bronskill
Format:	Article
Language:	English
Published:	BMC 2020-02-01
Series:	Implementation Science Communications
Subjects:	Antipsychotic prescribing Nursing homes Interrupted time series Audit and feedback
Online Access:	https://doi.org/10.1186/s43058-020-00013-9

Similar Items

Evaluation of an automated feedback intervention to improve antibiotic prescribing among primary care physicians (OPEN Stewardship): a multinational controlled interrupted time-series study
by: Jean-Paul R. Soucy, et al.
Published: (2024-04-01)

Impact on hospital-wide antipsychotic prescribing practices through physician peer comparison letters
by: Erica A. K. Davis, PharmD, BCPS, BCPP
Published: (2022-01-01)

Antipsychotic prescribing choices in patients with First Episode Psychosis
by: J. Fallon, et al.
Published: (2022-06-01)

A multiple-behaviour investigation of goal prioritisation in physicians receiving audit and feedback to address high-risk prescribing in nursing homes
by: Nicola McCleary, et al.
Published: (2020-02-01)

Antipsychotic prescribing patterns in Australia: a retrospective analysis
by: Nagesh Pai, et al.
Published: (2022-02-01)

Testing feedback message framing and comparators to address prescribing of high-risk medications in nursing homes: protocol for a pragmatic, factorial, cluster-randomized trial
by: Noah M. Ivers, et al.
Published: (2017-07-01)

Antipsychotic prescribing patterns in children and adolescents attending Australian general practice in 2011 and 2017
by: Julie Klau, et al.
Published: (2024-03-01)

Trends in antipsychotic prescribing for approved and unapproved indications to Medicaid-enrolled youth in Philadelphia, Pennsylvania between 2014 and 2018
by: Molly Candon, et al.
Published: (2021-10-01)

Prevalence and Cost of Antipsychotic Prescribing, within the Context of Psycholeptic Prescribing, in the Irish Setting
by: Muireann Vaughan, et al.
Published: (2024-01-01)

Antipsychotic prescribing for vulnerable populations: a clinical audit at an acute Australian mental health unit at two-time points
by: Sara S McMillan, et al.
Published: (2017-04-01)

Impact of COVID-19 Pandemic on Prescribing of Long-Acting Injectable Antipsychotics for Schizophrenia: Results from a United States Prescriber Survey
by: Zhdanava M, et al.
Published: (2022-09-01)

Engagement is a necessary condition to test audit and feedback design features: results of a pragmatic, factorial, cluster-randomized trial with an embedded process evaluation
by: Nicola McCleary, et al.
Published: (2023-05-01)

A scoping review of perceptions from healthcare professionals on antipsychotic prescribing practices in acute care settings
by: Natalia Jaworska, et al.
Published: (2022-10-01)

Off-label prescribing of antipsychotics: prescribing practices and clinical experiences of Finnish physicians
by: N. Rautio, et al.
Published: (2022-06-01)

Antipsychotic prescribing practices in real-life (APPREAL study): Findings from the French National Healthcare System Database (2007–2017)
by: Benjamin Rolland, et al.
Published: (2022-10-01)

Prescribing patterns of long-acting injectable antipsychotics in a community setting in South Africa
by: Nabila Veyej, et al.
Published: (2022-06-01)

Antipsychotic prescribing for Alzheimer’s disease and related disorders in specialized settings from 2010 to 2014 in France: a repeated cross-sectional study
by: Karim Tifratene, et al.
Published: (2017-04-01)

Comparison of antipsychotic prescribing practices following failure of antipsychotic monotherapy in the acute care setting
by: Kaitlyn Morgan, PharmD, BCPP, et al.
Published: (2023-01-01)

Prescribing of psychotropic medications to the elderly population of a Canadian province: a retrospective study using administrative databases
by: Silvia Alessi-Severini, et al.
Published: (2013-09-01)

The Prevalence and Factors Associated With Antipsychotic Polypharmacy in a Forensic Psychiatric Sample
by: Christian Farrell, et al.
Published: (2020-04-01)

Clozapine prescribing practice and trends in Qatar: First national observational study
by: Ovais Wadoo, et al.
Published: (2022-07-01)

Tackling myths of common prescribing patterns in schizophrenia amongst Egyptian psychiatrists
by: Samir Abolmagd, et al.
Published: (2020-12-01)

Rationalising Antipsychotic Prescribing in Dementia (RAPID) complex intervention: A mixed-methods feasibility intervention study
by: Kieran A. Walsh, et al.
Published: (2022-12-01)

An audit of antimicrobial prescribing by dental practitioners in the north east of England and Cumbria
by: A. Sturrock, et al.
Published: (2018-12-01)

Patient-psychiatrist discordance and drivers of prescribing long-acting injectable antipsychotics for schizophrenia management in the real-world: a point-in-time survey
by: Alexander Keenan, et al.
Published: (2022-03-01)

Prevalence and appropriateness of psychotropic medication prescribing in a nationally representative cross-sectional survey of male and female prisoners in England
by: Lamiece Hassan, et al.
Published: (2016-10-01)

Evaluating the Implementation of a Pilot Quality Improvement Program to Support Appropriate Antimicrobial Prescribing in General Practice
by: Ruby Biezen, et al.
Published: (2021-07-01)

OFF-LABEL PRESCRIBING OF ANTIPSYCHOTICS – A QUESTIONNAIRE SURVEY OF FINNISH PHYSICIANS
by: Jami Pentinlehto, et al.
Published: (2021-11-01)

Prescribing cascade in a geropsychiatric patient: A slippery slope
by: Patricia A Pepa, et al.
Published: (2018-01-01)

The Growing Trend of Prescribing Antipsychotics for Young People in Finland, 2000 to 2010
by: Kirsi-Maria Haapasalo-Pesu, et al.
Published: (2016-01-01)

Antipsychotic Polypharmacy and High Doses in a Rural Portuguese Community Mental Health Service
by: Sara Ramos, et al.
Published: (2021-09-01)

An Evaluation of the Impact of an OPEN Stewardship Generated Feedback Intervention on Antibiotic Prescribing among Primary Care Veterinarians in Canada and Israel
by: Kamal R. Acharya, et al.
Published: (2024-02-01)

Understanding the behavioural determinants of opioid prescribing among family physicians: a qualitative study
by: L. Desveaux, et al.
Published: (2019-05-01)

Prescribing practice of long-acting injectable antipsychotics
by: Jisha M Lucca, et al.
Published: (2020-01-01)

Real-World Patterns of Utilization and Costs Associated with Second-Generation Oral Antipsychotic Medication for the Treatment of Bipolar Disorder: A Literature Review
by: Doane MJ, et al.
Published: (2021-02-01)

Cross verification of prescribing trends through loop evaluation of physicians, patients and medical store personnel
by: Syed Zia Husnain, et al.
Published: (2019-05-01)

Prescription audit of a teaching hospital in South India using World Health Organization core prescribing indicators – A cross-sectional study
by: R Meenakshi, et al.
Published: (2022-01-01)

Documentation of antipsychotic-related adverse drug reactions: An educational intervention
by: Gregory Purcell, et al.
Published: (2019-11-01)

Patterns and predictors of oral antipsychotic prescribing in adult patients with schizophrenia
by: Nina Vadiei, et al.
Published: (2022-06-01)

Antibiotic Prescribing in Primary Care for Urinary Tract Infections (UTIs) in Pregnancy: An Audit Study
by: Flavia Ghouri, et al.
Published: (2020-09-01)